GSK1324726A Catalog No.:M9520-10 CC1=CC(N)=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]1=C2C=CC=CC2=C(N)C=C1C

CC1=CC(N)=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]1=C2C=CC=CC2=C(N)C=C1C

is a fibroblast growth factor receptor 4 (FGFR4) inhibitor potentially for the treatment of hepatocellular carcinoma and cholangiocarcinoma

2014 Apr 1

The inhibition rate (53

PF-04457845 inhibits the pain response to a comparable degree as the nonsteroidal anti-inflammatory drug naproxen at 10 mg/kg

GSK1324726A Catalog No.:M9520-10 CC1=CC(N)=C2C=CC=CC2=[N+]1CCCCCCCCCC[N+]1=C2C=CC=CC2=C(N)C=C1CI BET 726, also known as GSK1324726A, is a potent and selective inhibitor of BET family proteins. Oral administration of I BET726 to mouse xenograft models of human neuroblastoma results in tumor growth inhibition and down regulation MYCN and BCL2 expression, suggesting a potential role for these genes in tumor growth. Product information CAS Number: 1300031 52 0 Molecular Weight: 434. 91 Formula: C25H23ClN2O3 Chemical Name: 4 [(2S,4R) 1 acetyl 4 [(4